mdlinx mdlinx
Latest (18) Full Text Articles (297) Article Summary

Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Full Text
Cardiovascular Diabetology,

Mallat SG – Clinical studies suggest that in CV high–risk patients and those with evidence of renal disease, the use of an ARB/CCB combination may be preferred to ARB/HCTZ combinations due to superior renoprotective and CV benefits and reduced metabolic side effects in patients with concomitant metabolic disorders. However, selection of the most appropriate antihypertensive combination should be dependent on careful review of the individual patient and appropriate consideration of drug pharmacology.

  • Hypertension is a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular (CV) events, comorbid diabetes mellitus, microalbuminuria and renal impairment.
  • Given that most patients with hypertension require at least two antihypertensives to achieve blood pressure (BP) goals, identifying the most appropriate combination regimen based on individual risk factors and comorbidities is important for risk management.
  • Single–pill combinations (SPCs) containing two or more antihypertensive agents with complementary mechanisms of action offer potential advantages over free–drug combinations, including simplification of treatment regimens, convenience and reduced costs.
  • The improved adherence and convenience resulting from SPC use is recognised in updated hypertension guidelines.
  • Despite a wide choice of SPCs for hypertension treatment, clinical evidence from direct head–to–head comparisons to guide selection for individual patients is lacking.
  • However, in patients with evidence of renal disease or at greater risk of developing renal disease, such as those with diabetes mellitus, microalbuminuria and high–normal BP or overt hypertension, guidelines recommend renin–angiotensin system (RAS) blocker–based combination therapy due to superior renoprotective effects compared with other antihypertensive classes.
  • Furthermore, RAS inhibitors attenuate the oedema and renal hyperfiltration associated with calcium channel blocker (CCB) monotherapy, making them a good choice for combination therapy.
  • The occurrence of angiotensin–converting enzyme (ACE) inhibitor–induced cough supports the use of angiotensin II receptor blockers (ARBs) for RAS blockade rather than ACE inhibitors.
  • In this regard, ARB–based SPCs are available in combination with the diuretic, hydrochlorothiazide (HCTZ) or the calcium CCB, amlodipine.
  • Telmisartan, a long–acting ARB with preferential pharmacodynamic profile compared with several other ARBs, and the only ARB with an indication for the prevention of CV disease progression, is available in two SPC formulations, telmisartan/HCTZ and telmisartan/amlodipine.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Ophthalmology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Ophthalmology Articles

Last month's top read Top Articles of 2013

1 Is vitamin D status associated with open-angle glaucoma? Public Health Nutrition, March 6, 2014    Clinical Article

2 Association between aspirin use and age-related macular degeneration: A meta-analysis Investigative Ophthalmology & Visual Science, February 11, 2014    Evidence Based Medicine    Clinical Article

3 Complications of femtosecond laser-assisted cataract surgery EyeWorld, January 23, 2014    Clinical Article

4 Sleep apnoea and glaucoma Klinische Monatsblätter für Augenheilkunde, March 10, 2014    Clinical Article

5 Glaucoma - Diabetes of the brain: A radical hypothesis about its nature and pathogenesis Medical Hypotheses, March 7, 2014    Clinical Article
Exclusive Author Commentary

6 Normal-tension glaucoma and obstructive sleep apnea syndrome: A prospective study Full Text BMC Ophthalmology, March 13, 2014    Free full text    Clinical Article

7 Use of macular thickness parameters for the diagnosis of primary open-angle glaucoma Archives of Medical Science, March 3, 2014    Clinical Article

8 Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: Two randomized 12-week trials Full Text Clinical Ophthalmology, March 28, 2014    Free full text    Clinical Article

9 Ketamine and intraocular pressure in children Annals of Emergency Medicine, March 12, 2014    Clinical Article

10 Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis? Multiple Sclerosis Journal, March 20, 2014    Clinical Article

11 Comparison of toric intraocular lenses and arcuate corneal relaxing incisions to correct moderate to high astigmatism in cataract surgery Asia-Pacific Journal of Ophthalmology, March 26, 2014    Clinical Article

12 Unstable oxygen supply and glaucoma Klinische Monatsblätter für Augenheilkunde, March 5, 2014    Review Article    Clinical Article

13 Causes of subnormal vision in patients following cataract surgery International Ophthalmology, February 17, 2014    Clinical Article

14 Common antibiotic may combat dry eye disease Full Text EurekAlert!, December 24, 2013    Free full text

15 Efficacy and safety of a new surgical method to treat malignant glaucoma in pseudophakia Eye, March 24, 2014    Clinical Article

16 Snoring and glaucoma PLOS ONE, February 25, 2014    Clinical Article

17 Choroidal changes and duration of diabetes Seminars in Ophthalmology, March 4, 2014    Clinical Article

18 Physical inactivity as a risk factor for diabetic retinopathy? A review Clinical and Experimental Ophthalmology, March 11, 2014    Clinical Article

19 Xerophthalmia— a potential epidemic on our doorstep? Eye, February 27, 2014    Clinical Article

20 Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy a randomized clinical trial JAMA Ophthalmology, March 10, 2014    Clinical Article

Indexed Journals in Ophthalmology: American Journal of Ophthalmology, Retina, Eye, Corneamore

Other Topics in Ophthalmology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close